# Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia

> **NCT06695832** · — · ACTIVE_NOT_RECRUITING · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 369 (actual)

## Conditions studied

- Staphylococcus Aureus Bacteremia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06695832
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 369 (ACTUAL)
- **Last updated:** 2024-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06695832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06695832, "Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06695832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*